Conexeu Sciences (NASDAQ:CNXU) is developing a regenerative medicine platform that could change how damaged tissue is treated. The company’s CXU technology aims to move beyond replacement therapies by creating conditions that may help the body rebuild itself.
Interview date: July 1, 2026. The video was published on July 20, 2026. A portion of this video is sponsored by Simply Wall St. Dividend Aristocrats® is a registered trademark of Standard & Poor’s Financial Services LLC. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video. This video is for educational purposes only and not financial advice.
